NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%
Tue, 28 May

NATCO PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m7,6785,5674,557-18.1%-40.6%
Other incomeRs m20123331033.0%54.2%
TurnoverRs m7,8795,8004,867-16.1%-38.2%
ExpensesRs m3,8453,4833,074-11.7%-20.1%
Gross profitRs m3,8332,0841,483-28.8%-61.3%
DepreciationRs m1802072174.8%20.6%
InterestRs m306352-17.5%73.3%
Profit before taxRs m3,8242,0471,524-25.5%-60.1%
TaxRs m827454320-29.5%-61.3%
Profit after taxRs m2,9971,5931,204-24.4%-59.8%
Gross profit margin%49.937.432.5
Effective tax rate%21.622.221.0
Net profit margin%38.027.524.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 40.6% on a year-on-year (YoY) basis. The expenses were down by 20.1% YoY during the same period.
  • The company's operating profit declined by 61.3% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 32.5% in 4QFY19 as against 49.9% in 4QFY18.
  • Depreciation charges increased by 20.6% and finance costs increased by 73.3% YoY, respectively.
  • Other income increased by 54.2% YoY during the quarter.
  • Net profit for the quarter declined by 59.8% YoY. Net profit margins during the quarter declined from 38.0% in 4QFY18 to 24.7% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 18.1% on a quarter-on-quarter (QoQ) basis. The expenses were down by 11.7% QoQ during the same period.
  • The company's operating profit declined by 28.8% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 32.5% in 4QFY19 as against 37.4% in 3QFY18.
  • Net profit for the quarter declined by 24.4% QoQ, while net profit margins declined from 27.5% in 3QFY18 to 24.7% in 4QFY19.

To see how NATCO PHARMA has performed over the last eight quarters, please visit here.

NATCO PHARMA Share Price Performance

Over the last one year, NATCO PHARMA share price has moved up from Rs 796.7 to Rs 503.5, registering a Loss of Rs 293.2 or around 36.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,400.8 (up 0.3%). Over the last one year it has moved up from 13,319.5 to 13,400.8, a gain of 81 points (up 0.6%).

Overall, the S&P BSE SENSEX is up 12.7% over the year.

Current Valuations

At the current price of Rs 503.5, the price to earnings (P/E) ratio of NATCO PHARMA stands at 13.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.7 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

My Best Trading Ideas When Interest Rates Are So Low(Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Aug 5, 2020 01:29 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA 5-YR ANALYSIS

COMPARE NATCO PHARMA WITH

MARKET STATS